ACTM-838

· Actym Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACTM-838, covering 2025-10-15 to 2025-10-15. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors [Phase 1]